SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 29.86 |
| Enterprise Value ($M) | 29.79 |
| Book Value ($M) | 0.92 |
| Book Value / Share | 0.03 |
| Price / Book | 32.34 |
| NCAV ($M) | 0.83 |
| NCAV / Share | 0.03 |
| Price / NCAV | 35.81 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.97 |
| Return on Assets (ROA) | -0.46 |
| Return on Equity (ROE) | -1.29 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.98 |
| Current Ratio | 3.98 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.81 |
| Assets | 7.89 |
| Liabilities | 6.97 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.50 |
| Operating Income | -5.88 |
| Net Income | -5.81 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -3.97 |
| Cash from Investing | -1.88 |
| Cash from Financing | 5.85 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Francisco Trust under agreement dated February 28, 1996 | 11.52 | -3.89 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| Form 10-K for the year ended December 31, 2024 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,254 | 51,789 | 25.59 | |
| 4,649 | 28,268 | 16.45 | |
| 3,393 | 13,122 | 25.86 | |
| 11,405 | 18,744 | 60.85 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DRUG – Bright Minds Biosciences Inc. | DTIL – Precision BioSciences, Inc. |
| DWTX – Dogwood Therapeutics, Inc. | EDSA – Edesa Biotech, Inc. |
| ELDN – Eledon Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io